Pizarra, Teodoro S.

HRN: 01-77-72  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/07/2022
CEFTRIAXONE 1G (VIAL)
12/07/2022
12/13/2022
IV
2gm
Q24
UTI
Waiting Final Action 
12/09/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/09/2022
12/15/2022
IVT
600mg
Q8
Psoas Abscess, Right
Waiting Final Action 
12/11/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/11/2022
12/17/2022
IV
600mg
Q6
Psoas Abscess
Waiting Final Action 
12/12/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/12/2022
12/18/2022
IV
4.5g
Q8
T/C GI TB, Psoas Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: